Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi There’s welcome news in the battle against the Ebola virus, an infectious disease that for years had almost no treatments or remedies. Outbreaks of the deadly Ebola virus flare up in parts of Africa almost every year, and they’re vicious. The […]
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A long-simmering scientific battle assumed a new life this week, as experts clashed in a San Francisco courtroom over whether the U.S. Environmental Protection Agency (EPA) should ban fluoridation of drinking water to protect foetuses and children from the risk of
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi After a 60-year quest, childhood malaria vaccinations were administered to infants and toddlers in Cameroon on 22 January, the world’s first routine immunization against the disease. Remarkably, the RTS,S or Mosquirix, made by GlaxoSmithKline and approved for general use in 2021
Malaria vaccine rolled out in Cameroon; The latest health stories from around the world Read More »
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Eli Lilly, maker of the anti-obesity drug Zepbound, announced last week the launch of LillyDirect, a direct-to-patient portal, allowing some patients to obtain its drug for as little as $25 a month. The move is seen as a major shift in the way
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Consulting firm McKinsey & Co has agreed to pay $78 million to resolve claims by U.S. health insurers and benefit plans that it fuelled an epidemic of opioid addiction through its work for drug companies including OxyContin maker Purdue Pharma. https://www.reuters.com/legal/mckinsey-pay-78-million-us-opioid-settlement-with-health-plans-2023-12-30/
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi US President Joe Biden has stepped into a long-running debate about whether the National Institutes of Health (NIH) has legal authority to override an exclusive patent license granted to drug developers if they charge too much for treatments that relied on
Biden weighs in on drug costs in US; The latest health stories from around the world Read More »
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Six months after announcing the $5 billion Project NextGen to develop treatments and vaccines that can “stay ahead of COVID-19,” the U.S. government has awarded 20 contracts that reveal what much of that sum will support. The Department of Health and
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The 2023 Nobel Prize in Physiology or Medicine has been jointly awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19 https://www.nobelprize.org/prizes/medicine/2023/press-release/ The discoveries by the two
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi After the US Food and Drug Administration authorized new monovalent COVID vaccines on early last week, the Centers of Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices backed the decision a day later with a nearly unanimous vote in favour of universal XBB-containing
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from “Eris”, a variant of the Omicron form of the coronavirus, rise around the country. https://www.reuters.com/business/healthcare-pharmaceuticals/new-covid-vaccines-are-way-eris-variant-rises-2023-08-14/
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
